Full Press Release Details
AC Immune Completes Recruitment For Low Dose Cohort in World s First Clinical Trial For Anti Abeta Vaccine Targeting Alzheimer s Disease Like Characteristics in Individuals With Do.
ACIU
AC Immune Completes Recruitment For Low Dose Cohort in World s First Clinical Trial For Anti Abeta Vaccine Targeting Alzheimer s Disease Like Characteristics in Individuals With Do
Key Takeaway: AC Immune Completes Recruitment For Low Dose Cohort in World s First Clinical Trial For Anti Abeta Vaccine Targeting Alzheimer s Disease Like Characteristics in Individuals With Do